XML 22 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2020
Operating Activities:      
Net income $ 13,737 $ 631 $ 16,660
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Depreciation and amortization 9,358 10,335 10,538
Gain on sale of division (2,006) 0 0
Stock-based compensation 4,090 2,583 3,474
Bad debt expense, net 162 48 258
Deferred income taxes (4,861) (995) 1,473
Gain on cash surrender value of life insurance 0 0 (506)
Changes in operating assets and liabilities:      
Accounts receivable, net (31,629) (7,509) 41,969
Contract assets and liabilities, net 3,122 (39,951) 12,546
Inventories (21,426) (599) 304
Income taxes 688 (473) 720
Prepaid expenses and other current assets (2,577) 412 662
Accounts payable 18,594 9,760 (15,309)
Accrued liabilities 8,908 (3,151) 465
Other, net 258 (1,552) (860)
Net cash provided by (used in) operating activities (3,582) (30,461) 72,394
Investing Activities:      
Purchases of short-term investments (22,381) (27,735) (18,553)
Maturities of short-term investments 26,320 27,688 6,146
Proceeds from sale of division 4,348 0 0
Purchases of property, plant and equipment (2,451) (2,931) (5,163)
Proceeds from sale of property, plant and equipment 629 40 33
Proceeds from life insurance policy 0 474 0
Net cash provided by (used in) investing activities 6,465 (2,464) (17,537)
Financing Activities:      
Payments on industrial development revenue bonds (400) (400) (400)
Shares withheld in lieu of employee tax withholding (675) (632) (629)
Dividends paid (12,233) (12,142) (12,066)
Net cash used in financing activities (13,308) (13,174) (13,095)
Net increase (decrease) in cash, cash equivalents and restricted cash (10,425) (46,099) 41,762
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1,935) 197 (185)
Cash, cash equivalents and restricted cash at beginning of period 114,314 160,216 118,639
Cash, cash equivalents and restricted cash at end of period $ 101,954 $ 114,314 $ 160,216